Woodland Hills, Calif.-based Endonovo Therapeutics announced a new awareness campaign for its FDA-cleared pain relief solution for patients post-surgery, according to an Oct. 8 press release.
The SofPulse device is a wearable that uses targeted pulsed electromagnetic field technology to reduce swelling and speed up natural recovery processes, reducing the need for pain medication, according to its website.
"Endonovo's public awareness campaign will focus on educating hospitals and MDs regarding SofPulse’s proven ability to reduce pain and edema post-operatively while significantly reducing costs associated with surgeries," Alan Collier, Endonovo CEO, said in a statement.
Read the full release here.
More articles on surgery centers:
CRH, physicians open anesthesia practice
New guidelines to reduce post-surgery opioid prescriptions miss subset of patients, researchers say
Collegium, Teva reach settlement over extended-release oxycodone patent